Literature DB >> 32278370

The gendered dimensions of COVID-19.

.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32278370      PMCID: PMC7146664          DOI: 10.1016/S0140-6736(20)30823-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
SARS-CoV-2 does not discriminate, but without careful consideration, the global response to the COVID-19 pandemic might. Demographic data from small studies are already informing political decisions and clinical research strategies. Women and men are affected by COVID-19, but biology and gender norms are shaping the disease burden. The success of the global response—the ability of both women and men to survive and recover from the pandemic's effects—will depend on the quality of evidence informing the response and the extent to which data represent sex and gender differences. Global Health 50/50 tracks sex-disaggregated infection and mortality COVID-19 data from the 39 most-affected countries. Some countries, including the UK, the USA, Russia, and Brazil, have yet to report such data. From those that have, it is unclear whether women or men are more likely to become infected, but more men are dying from COVID-19. Adverse outcomes of COVID-19 seem to be associated with comorbidities, including hypertension, cardiovascular disease, and lung disease. These conditions are more prevalent in men and are linked to smoking and drinking alcohol—behaviours associated with masculine norms. Women carry a different kind of burden from COVID-19. Inequities disproportionately affect their wellbeing and economic resilience during lockdowns. Households are under strain, but child care, elderly care, and housework typically fall on women. Concerns over increased domestic violence are growing. With health services overstretched and charities under-resourced, women's sexual and reproductive health services, as well as prenatal and postnatal care, are disrupted. The European Association of Science Editors and other organisations urge all involved in collecting COVID-19 data to follow guidelines (eg, CONSORT, STROBE) and include age and sex in demographic data. We echo this call and encourage a gender focus in all research efforts. Obscuring sex and gender differences in treatment and vaccine development could result in harm. Incomplete reporting compromises meta-analyses. Addressing the health needs of men and women equally will help societies recover and resist future human tragedies.
  49 in total

1.  Impact of mandatory social isolation measures due to the COVID-19 pandemic on the subjective well-being of Latin American and Caribbean dentists.

Authors:  María-Claudia Garcés-Elías; Roberto A León-Manco; Ana Armas-Vega; Andrés Viteri-García; Andrés A Agudelo-Suárez
Journal:  J Clin Exp Dent       Date:  2022-01-01

2.  Menstrual Product Insecurity Resulting From COVID-19‒Related Income Loss, United States, 2020.

Authors:  Marni Sommer; Penelope A Phillips-Howard; Caitlin Gruer; Margaret L Schmitt; Angela-Maithy Nguyen; Amanda Berry; Shivani Kochhar; Sarah Gorrell Kulkarni; Denis Nash; Andrew R Maroko
Journal:  Am J Public Health       Date:  2022-04       Impact factor: 9.308

3.  Precarity in a Time of Uncertainty: Gendered Employment Patterns during the Covid-19 Lockdown in India.

Authors:  Sonalde Desai; Neerad Deshmukh; Santanu Pramanik
Journal:  Fem Econ       Date:  2021-03-01

4.  Sex-Based Differences in COVID-19 Outcomes.

Authors:  Astha Tejpal; Eugenia Gianos; Jane Cerise; Jamie S Hirsch; Stacey Rosen; Nina Kohn; Martin Lesser; Catherine Weinberg; David Majure; Sanjaya K Satapathy; David Bernstein; Matthew A Barish; Alex C Spyropoulos; Rachel-Maria Brown
Journal:  J Womens Health (Larchmt)       Date:  2021-04       Impact factor: 2.681

5.  The Differential Impact of Lockdown Measures Upon Migrant and Female Psychiatric Patients - A Cross-Sectional Survey in a Psychiatric Hospital in Berlin, Germany.

Authors:  James K Moran; Joachim Bretz; Johanna Winkler; Stefan Gutwinski; Eva J Brandl; Meryam Schouler-Ocak
Journal:  Front Psychiatry       Date:  2021-05-28       Impact factor: 5.435

6.  Demographic and territorial characteristics of COVID-19 cases and excess mortality in the European Union during the first wave.

Authors:  Anne Goujon; Fabrizio Natale; Daniela Ghio; Alessandra Conte
Journal:  J Popul Res (Canberra)       Date:  2021-05-29

7.  Assessing the Country-Level Excess All-Cause Mortality and the Impacts of Air Pollution and Human Activity during the COVID-19 Epidemic.

Authors:  Yuan Meng; Man Sing Wong; Hanfa Xing; Mei-Po Kwan; Rui Zhu
Journal:  Int J Environ Res Public Health       Date:  2021-06-26       Impact factor: 3.390

8.  A Real-World Evidence Framework for Optimizing Dosing in All Patients With COVID-19.

Authors:  Richard W Peck; Daniel Weiner; Jack Cook; J Robert Powell
Journal:  Clin Pharmacol Ther       Date:  2020-06-29       Impact factor: 6.903

9.  Risk factors for mortality among COVID-19 patients.

Authors:  Orwa Albitar; Rama Ballouze; Jer Ping Ooi; Siti Maisharah Sheikh Ghadzi
Journal:  Diabetes Res Clin Pract       Date:  2020-07-03       Impact factor: 5.602

10.  Priorities and opportunities for palliative and end of life care in United Kingdom health policies: a national documentary analysis.

Authors:  Katherine E Sleeman; Anna Timms; Juliet Gillam; Janet E Anderson; Richard Harding; Elizabeth L Sampson; Catherine J Evans
Journal:  BMC Palliat Care       Date:  2021-07-14       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.